Listen: Pharma goes to Washington, Alnylam’s future, & Gilead’s dealmaking
STAT
FEBRUARY 15, 2024
STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices.
84 
Let's personalize your content